Your browser doesn't support javascript.
loading
Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era.
Zhang, Nianhai; Xu, Deming; Liu, Bo; Shi, Xi; Xie, Xianhe; Wang, Zili.
Afiliação
  • Zhang N; Department of Oncology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350000, China.
  • Xu D; Department of Oncology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350000, China.
  • Liu B; Department of Thoracic Surgery, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350000, China.
  • Shi X; Department of Oncology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350000, China.
  • Xie X; Department of Oncology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350000, China; Molecular Oncology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350000, China. Electronic address: xiexianhe@fjmu.edu.cn.
  • Wang Z; Department of Oncology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350000, China. Electronic address: wangzili83@163.com.
Int Immunopharmacol ; 113(Pt A): 109299, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36252471

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Neoplasias do Sistema Nervoso Central Tipo de estudo: Etiology_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Neoplasias do Sistema Nervoso Central Tipo de estudo: Etiology_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China